XtalPi Enters into Collaboration with Eli Lilly to Discover Drug Candidates Using Artificial Intelligence and Robotics Platform
By Ashish Tripathi
Pharma Deals Review: Vol 2023 Issue 6 (Table of Contents)
Published: 20 Jun-2023
DOI: 10.3833/pdr.v2023.i6.2792 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Eli Lilly has entered into an artificial intelligence (AI) drug discovery collaboration with XtalPi, which is worth up to US$250 M and will provide Lilly with access to XtalPi’s ID4Inno™ drug discovery platform to design and deliver drug candidates for an undisclosed target...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS